SPG released its performance for the first three quarters, with a net profit attributable to the parent company of 542 million yuan, a year-on-year decrease of 24.7%

According to the Zhitong Finance APP, Shandong Pharmaceutical Glass (600529.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 3.401 billion yuan in the first three quarters, a year-on-year decrease of 11.10%; the net profit attributable to shareholders was 542 million yuan, a year-on-year decrease of 24.7%; the net profit excluding non-recurring gains and losses was 516 million yuan, a year-on-year decrease of 25.13%; the basic earnings per share were 0.8174 yuan